TP53 and acute myeloid leukemia: Consistent results were also obtained with MV-4–11 AML cells were lentiviral miR-221 infection decreased the expression of YOD1 and p53, whereas lentiviral anti-miR-221 enhanced its expression (Fig. 5C).